{
    "2020-02-23": [
        [
            {
                "time": "2023-01-01",
                "original_text": "【山证医药】1月血制品批签发数据跟踪：1月批签发总体稳定，疫情下静丙需求量大幅提升",
                "features": {
                    "keywords": [
                        "血制品",
                        "批签发",
                        "疫情",
                        "静丙",
                        "需求量"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-20",
                "original_text": "富时罗素扩容A股因子至25% 3月20日收盘后生效",
                "features": {
                    "keywords": [
                        "富时罗素",
                        "扩容",
                        "A股",
                        "因子"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-02-23",
                "original_text": "等闲不识医药面，核心资产总是牛！【西南证券医药|0223周报】",
                "features": {
                    "keywords": [
                        "医药",
                        "核心资产"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-01-01",
                "original_text": "批签发同比快速增长，进度未受影响【安信医药战略推荐血制品系列9】批签发数据实时跟踪",
                "features": {
                    "keywords": [
                        "批签发",
                        "同比增长",
                        "血制品"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}